| 1888 Press Release | Technology News | Biotechnology News | Biotechnology RSS |  |
Latest Biotechnology News & Press Releases |
||
|
Announcing GTC's Cardiac Centers of Excellence Conference, May 15-17,2012 at the Meliá Atlanta Hotel
GTC is pleased to announce the Cardiac Centers of Excellence Conference to be held May 15-17, 2012 at the Meliá Atlanta hotel in Atlanta, GA. By Gtcbio - May 15, 2012 |
|
Brad Spellberg at 9th Anti-infectives Partnering summit July 9, 2012 California
Brad Spellberg, Associate Professor of Medicine at UCLA Medical Center will give a keynote presentation on "The Future of Antibiotic R&D" at the 9th Anti-Infectives Partnering and Deal-making Conference taking place on July 9-10, 2012 in San Francisco, CA. By Gtcbio - May 10, 2012 |
|
Maureen Gibbons at BMS, to speak at Life Science Legal Strategy Conference in San Diego on June 7-8
Maureen Gibbons, who serves as senior corporate counsel at Bristol-Myers Squibb Co., will join the Life Science Legal & Business Strategy Conference as a speaker, GTC has announced. The conference is scheduled June 7-8, 2012 at the Hilton San Diego Resort & Spa. By Gtcbio - May 10, 2012 |
|
OrbiMed, 5AM Ventures, Frazier, and Aisling at 9th Anti-infectives Partnering Conference July 9 2012
Joseph Larsen, Chief of Broad Spectrum Antimicrobials (BSA) Program and Division of CBRN Countermeasures at DHHS / ASPR / BARDA will give a featured presentation about Partnering and Working with BARDA at the 9th Anti-Infectives Partnering and Deal-making Conference taking place on July 9-10, 2012 in San Francisco, CA. By Gtcbio - May 09, 2012 |
|
Chief at BARDA to speak at 9th Anti-infectives Partnering conference July 9-10, 2012 California
Joseph Larsen, Chief of Broad Spectrum Antimicrobials (BSA) Program and Division of CBRN Countermeasures at DHHS / ASPR / BARDA will give a featured presentation about Partnering and Working with BARDA at the 9th Anti-Infectives Partnering and Deal-making Conference taking place on July 9-10, 2012 in San Francisco, CA. By Gtcbio - May 09, 2012 |
|
Microfluidics Specialist Dolomite joins forces with LioniX B.V.
Dolomite and LioniX B.V. join forces in the areas of designing, developing and fabricating microfluidic devices and systems which enable them to expand the range of leading-edge customised solutions to their clients. By The Dolomite Centre Ltd - May 03, 2012 |
|
Patrick Terry, Scientia Advisors, presents at Genome-wide Partnering & Deal-making, May 30-31, Boston
Patrick Terry, Principle, Scientia Advisors LLC, will be giving a presentation entitled "Financing, Partnering, and Dealmaking in Stratified Medicine" at the Genome-wide Partnering & Deal-making Conference, May 30-31, 2012 in Boston, MA. By Gtcbio - April 28, 2012 |
|
Edmond Yunis to speak at Antibody Conference June 7-8, 2012 in San Diego, CA
Edmond Yunis, Professor of Pathology at Harvard Medical School and Chief of Immunogenetics at the Dana-Farber Cancer Institute will give a featured presentation on "Humoral Mechanisms and Molecular Signatures of Latent Tuberculosis Infection" at GTC's Antibody Design and Discovery Conference (June 7-8, 2012 in San Diego, CA). By Gtcbio - April 25, 2012 |
|
John E. Hennessy, Kansas City Cancer Center to speak at Cancer Conf, May 15-17, in Atlanta, GA
Addressing the timely issue of oncology reimbursements, John E. Hennessy, Executive Director, CCP, Kansas City Cancer Center/University of Kansas Cancer Center, will present at the Cancer Centers of Excellence Conference. By Gtcbio - April 24, 2012 |
|
Gail Nunlee-Bland, MD, Howard University Hospital to speak at conference, May 15-17, in Atlanta, GA
Telehealth's positive impact on health outcomes in the treatment of diabetes will be discussed in a presentation by Gail Nunlee-Bland, MD, Director and Chief of Endocrinology, Diabetes Treatment Center, Howard University Hospital at the Diabetes Centers of Excellence Conference. By Gtcbio - April 24, 2012 |
|
Biotage unveils Isolera Spektra with full PDA Spectral Scanning
Biotage, a leading global supplier of solutions and technology for analytical and medicinal chemistry, introduced Isolera™ Spektra. By Star One Public Relations - April 13, 2012 |
|
Alexander Hillisch from Bayer, to speak at Medicinal Chem. Conf. (June 7-8, 2012, San Diego)
Alexander Hillisch, Director of Medicinal Chemistry & Head of Computational Chemistry at Bayer to give a Featured Presentation on "Ligand and Structure-based ADMET Prediction: Tools and Applications in Lead Finding and Optimization" at the 6th Drug Design & Medicinal Chemistry Conference(June 7-8, 2012 in San Diego, CA). By Gtcbio - April 12, 2012 |
|
Steven Burill, to give plenary keynote at Genome-wide Partnering & Deal-making, May 30-31, Boston
G. Steven Burill, CEO, Burill &Co. will be giving a plenary keynote presentation entitled "Innovating in the New Austerity: What's Really Happening and Why Creative Dealmaking is Essential" at the Genome-wide Partnering & Deal-making conference (May 30-31, 2012 in Boston, MA). By Gtcbio - April 12, 2012 |
|
The Joint Commission to speak at Cancer Centers of Excellence Conference
The Cancer Centers of Excellence Conference will be held May 15-17, 2012 in the Meliá Atlanta hotel, conference producer GTC has confirmed. By Gtcbio - April 10, 2012 |
|
Rab Prinjha, Head at GSK to speak at 2nd Epigenetics Conference May 30-31, 2012 Boston
Rab Prinjha, Interim Head of Epinova Epigenetics DPU and Head of Biology at GlaxoSmithKline will give a featured presentation on "Epigenetic Modification in the Treatment of Immunoinflammatory Diseases" at the 2nd Epigenetics in Drug Discovery Conference taking place on May 30-31, 2012 in Boston, MA. By Gtcbio - April 09, 2012 |
|
Richard Weinshilboum to give keynote at Genomic/Proteomic Drug Discovery meeting, May 30-31, Boston
Richard Weinshilboum, Professor of Molecular Pharmacology & Experimental Therapeutics at the Mayo Clinic College of Medicine will be giving the keynote presentation entitled "Pharmacogenomics: Beyond Biomarkers" at the 2nd Genomic & Proteomic Drug Discovery Conference on May 29-31st, 2012 in Boston, MA by GTC. By Gtcbio - April 09, 2012 |
|
Richard Weinshilboum to give keynote at Genomic/Proteomic Drug Discovery meeting, May 30-31, Boston
Richard Weinshilboum, Professor of Molecular Pharmacology & Experimental Therapeutics at the Mayo Clinic College of Medicine will be giving the keynote presentation entitled "Pharmacogenomics: Beyond Biomarkers". By Gtcbio - April 08, 2012 |
Xybion's Harry Huss To Present At The SQA Annual Meeting In Miami
|
|
Craig C. Mello to speak at 3rd RNAi Research and Therapeutics conference May 30-31, 2012 Boston, MA
Craig C. Mello, Distinguished Professor of Molecular Medicine at the University of Massachusetts Medical School and Nobel Laureate, will give a keynote presentation on "RNAi and Immortality: Recognition of Self/Non-Self Nucleic Acids" at the 3rd RNAi Research and Therapeutics Conference taking place on May 30-31, 2012 in Boston, MA. By Gtcbio - March 24, 2012 |
|
PREMIER Biosoft Releases Beacon Designer(TM) 8.0 with Support for Exon Junction Primer Design
PREMIER Biosoft releases Beacon Designer™ with support for exon junction primer design. By Premier Biosoft International/ Neil Watson - March 23, 2012 |
|
The Joint Commission to speak at Healthcare Centers of Excellence Summit
M. J. Hampel, MPH, MBA, Senior Associate Director, Disease Specific Certification, The Joint Commission will serve as a keynote speaker at the Healthcare Centers of Excellence Summit. The Summit is scheduled May 15-17, 2012 at the Meliá Atlanta hotel. By Gtcbio - March 21, 2012 |
|
"Developing a Sustainable Healthcare Business Model" workshop to be held on May 15, 2012 in Atlanta
GTC is proud to announce the Pre-Summit Workshop, "Developing a Sustainable Healthcare Business Model." The workshop to be held on May 15th, 2012 will directly precede the Healthcare Centers of Excellence Summit at the Meliá Atlanta Hotel in Atlanta, GA. By Gtcbio - March 16, 2012 |
|
Richard Lewis at Amgen to Speak at the 7th Protein Kinases Conference - May 30-31, 2012 in Boston
Richard Lewis, Principal Scientist, Amgen to give a Presentation on "The Discovery & Optimisation of a Novel Class of Potent, Selective and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer" at the 7th Protein Kinases in Drug Discovery Conference (May 30-31, 2012 in Boston, MA) By Gtcbio - March 16, 2012 |
|
BrainStorm Cell Therapeutics Expands Pipeline with the Initiation of a Study for Multiple Sclerosis
Proposed Trial Will Build on NurOwn(TM) Platform to Meet Unmet Needs of Patients with Neurodegenerative Disorders. By Star One Public Relations - March 14, 2012 |
RST and Trelleborg Protective Products jointly decide to discontinue their distributor-manufacturer relationship
|
|
T. Forcht Dagi at HLM Venture Partners to speak at the 2nd Diabetes Summit, April 19-20, 2012 Boston
T. (Teo) Forcht Dagi, Partner at HLM Venture Partners will give a featured presentation about "Funding Opportunities and What Venture Capitalists Seek in a Diabetes Investment" at the 2nd Diabetes Summit to be held on April 19-20, 2012 in Boston, MA by GTC. By Gtcbio - March 12, 2012 |
|
James F. List, Vice President, at BMS to speak at Diabetes Summit, April 19-20, 2012 Boston, MA
James F. List, Vice President, Full Development Lead, Dapagliflozin, Metabolics, R&D, Bristol-Myers Squibb will participate in the panel discussion called "Beyond HbA1c - Are there Better Endpoints for Clinical Trials?" at the 2nd Diabetes Summit to be held on April 19-20, 2012 in Boston, MA by GTC. Other panelists in the panel discussion include Lane Desborough, Product Strategist, Medtronic, By Gtcbio - March 09, 2012 |
|
Hans-Juergen Woerle, VP at Boehringer Ingelheim, to speak at Diabetes Summit, April 2012 Boston
Hans-Juergen Woerle, Vice President and Head of Therapeutic Area Metabolism at Boehringer Ingelheim, Ingelheim, Germany, will be giving a plenary keynote presentation at the 2nd Diabetes Summit (April 19-20, 2012 in Boston, MA) By Gtcbio - March 08, 2012 |
|
Vice Presidents and Directors of Big Pharmas to speak at Diabetes Summit, April 19-20, 2012 Boston
Vice Presidents and Directors of Big Pharmas - Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Janssen, Merck, Novartis, Novo Nordis, Pfizer, Roche, Sanofi and many more will speak at the 2nd Diabetes Summit (April 19-20, 2012 in Boston, MA). By Gtcbio - March 06, 2012 |
|
Ralph DeFronzo, Diabetes Div Chief University of Texas to speak at Diabetes Summit April 2012 Boston
Ralph A. DeFronzo, MD, Professor of Medicine and Chief of the Diabetes Division at the University of Texas Health Science Center and the Audie L. Murphy Memorial VA Hospital in San Antonio, Texas), will be giving a presentation entitled "Treatment of T2DM Should be Based on Established Pathophysiologic Abnormalities" at the 2nd Diabetes Summit to be held on April 19-20, 2012 in Boston, MA by GTC. By Gtcbio - March 06, 2012 |
| 1 2 3 4 5 6 7 8 9 10 11 Next Last Page |
 |
| Search |
| Search Press Release: |
| Newsletter |
| Bookmark Biotechnology RSS |
|
|
